6576 - 6600 of 7730 Results
Title
Year
-
RESTRICTEDTitle: A visual review of the interactome of LRRK2: Using deep‐curated molecular interaction data to represent biologyJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 8Start Page: 1390End Page: 1404Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/pmic.201400390Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.201400390Citation Count: 38
- Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene2015RESTRICTEDTitle: Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 981End Page: 986Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26213Best OA location URL: https://europepmc.org/articles/pmc4478229?pdf=renderCitation Count: 55
-
RESTRICTEDTitle: Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0008-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0008-9Citation Count: 131
-
RESTRICTEDTitle: Constructing de Novo H2O2 Signaling via Induced Protein ProximityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 6Start Page: 1404End Page: 1410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b00170Best OA location URL: https://europepmc.org/articles/pmc4849873?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Low‐variance RNAs identify Parkinson's disease molecular signature in bloodJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26205Best OA location URL: https://europepmc.org/articles/pmc4439364?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [11C]‐(+)‐PHNO and [11C]raclopride positron emission tomography imaging studyJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 7Start Page: 2592End Page: 2601Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/hbm.22793Best OA location URL: https://europepmc.org/articles/pmc6869505?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Extracellular vesicle sorting of α-Synuclein is regulated by sumoylationJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 129Issue #: 5Start Page: 695End Page: 713Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-015-1408-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-015-1408-1.pdfCitation Count: 145
- Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acid2015RESTRICTEDTitle: Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acidJournal Name: Journal of NeurochemistryPublisher: WileyVol: 133Issue #: 6Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13074Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13074Citation Count: 46
-
RESTRICTEDTitle: Structural alterations of the intestinal epithelial barrier in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-015-0196-0Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-015-0196-0Citation Count: 205
-
RESTRICTEDTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: https://europepmc.org/articles/pmc4855523?pdf=renderCitation Count: 242
-
RESTRICTEDTitle: Differential effects of severe vs mild GBA mutations on Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 9Start Page: 880End Page: 887Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001315Best OA location URL: https://europepmc.org/articles/pmc4351661?pdf=renderCitation Count: 282
-
RESTRICTEDTitle: 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated miceJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 92Issue #:Start Page: 86End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neures.2014.11.005Citation Count: 51
-
RESTRICTEDTitle: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patientsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 591Issue #:Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013Best OA location URL: https://europepmc.org/articles/pmc4382517?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: BDNF polymorphism associates with decline in set shifting in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1605.e1End Page: 1605.e6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.08.023Citation Count: 37
-
RESTRICTEDTitle: Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cellsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 202Issue #:Start Page: 108End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2015.02.005Citation Count: 18
-
RESTRICTEDTitle: CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 3Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.12.027Best OA location URL: https://europepmc.org/articles/pmc4603566?pdf=renderCitation Count: 81
-
RESTRICTEDTitle: Isolation and characterization of antibody fragments selective for toxic oligomeric tauJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1342End Page: 1355Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.002Best OA location URL: https://europepmc.org/articles/pmc4346425?pdf=renderCitation Count: 24
-
RESTRICTEDTitle: Sarcopenia and impairment in cognitive and physical performanceJournal Name: Clinical Interventions in AgingPublisher: Informa UK LimitedVol:Issue #:Start Page: 663End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cia.s76275Best OA location URL: https://www.dovepress.com/getfile.php?fileID=24358Citation Count: 87
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015RESTRICTEDTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927027Citation Count: 52
-
RESTRICTEDTitle: Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome FunctionJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 6Issue #: 4Start Page: 588End Page: 598Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/cn500323qBest OA location URL: https://europepmc.org/articles/pmc4838453?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: Placebo effect of medication cost in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 8Start Page: 794End Page: 802Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001282Best OA location URL: https://europepmc.org/articles/pmc4345649?pdf=renderCitation Count: 112
-
RESTRICTEDTitle: Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier GenesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2015.00027Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2015.00027/pdfCitation Count: 7
-
RESTRICTEDTitle: Computational analysis of the LRRK2 interactomeJournal Name: PeerJPublisher: PeerJVol: 3Issue #:Start Page: e778End Page: e778Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.778Best OA location URL: https://doi.org/10.7717/peerj.778Citation Count: 50
-
RESTRICTEDTitle: Can Parkinson’s disease be cured by stimulating neurogenesis?Journal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 3Start Page: 978End Page: 980Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci80822Best OA location URL: http://www.jci.org/articles/view/80822/files/pdfCitation Count: 10
-
RESTRICTEDTitle: Molecular imaging of levodopa-induced dyskinesiasJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 72Issue #: 11Start Page: 2107End Page: 2117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-1854-xCitation Count: 17